Older Adults Face Four Vaccine Decisions This Fall While the Federal Schedule Still Carries a 2025 Date - Medical Daily

Latest News About Osivax and GC Biopharma join forces for flu vaccine combo

Osivax and GC Biopharma revealed a new alliance aimed at developing a more advanced influenza vaccine. The vaccine aims to combine OVX836 and GC FLU. Osivax secured rights to pursue a combined shot.

Older adults are facing four vaccine decisions this fall, while the federal immunization calendar continues to carry a 2025 date. Flu and pneumonia deaths have dropped for 25 years, but one American age group posted an uptick.

Sources & References